Cancer is one of the most fatal diseases of recent times that causes several deaths every
year. The disease variations in different parts of the world, the impact of available medical …

Countless expectations converge in the multidisciplinary endeavour for the search and
development of effective and safe drugs in fighting cancer. Although they still embody a …

Cancer is one of the major causes of death worldwide. Chemotherapeutic drugs have
become a popular choice as anticancer agents. Despite the therapeutic benefits of …

The identification of contributing factors leading to the development of Colorectal Cancer
(CRC), as the third fatal malignancy, is crucial. Today, the tumor microenvironment has been …

Simple Summary Radiotherapy (RT) is used worldwide as a gold standard treatment
approach for cancer management. However, the RT treatment modality contains limitations …

Metal complexes in cancer therapy have attracted much interest mainly because metals
exhibit unique characteristics, such as redox activity, metal‐ligand interaction, structure and …

A novel ruthenium (III)–pyrimidine Schiff base was synthesized and characterized using
different analytical and spectroscopic techniques. Molecular geometries of the ligand and …

A new series of nanostructured materials was obtained by functionalization of SBA-15
mesoporous silica with Ru (II) and Ru (III) complexes bearing Schiff base ligands derived …

Taxol is the first-line drug for cancer treatment. However, tumor resistance to Taxol is still a
significant challenge in clinical practice. Here, we studied the synergistic effect of a …

Neurodegenerative diseases are often characterized by the formation of aggregates of
amyloidogenic peptides and proteins, facilitating the formation of neurofibrillary plaques. In …